IN2012DN05209A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN05209A IN2012DN05209A IN5209DEN2012A IN2012DN05209A IN 2012DN05209 A IN2012DN05209 A IN 2012DN05209A IN 5209DEN2012 A IN5209DEN2012 A IN 5209DEN2012A IN 2012DN05209 A IN2012DN05209 A IN 2012DN05209A
- Authority
- IN
- India
- Prior art keywords
- crystalline form
- bimatoprost
- new
- date
- designated
- Prior art date
Links
- AQOKCDNYWBIDND-FTOWTWDKSA-N bimatoprost Chemical compound CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1 AQOKCDNYWBIDND-FTOWTWDKSA-N 0.000 abstract 3
- 229960002470 bimatoprost Drugs 0.000 abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/39—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26347109P | 2009-11-23 | 2009-11-23 | |
| PCT/US2010/057494 WO2011063276A1 (en) | 2009-11-23 | 2010-11-19 | 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN05209A true IN2012DN05209A (es) | 2015-10-23 |
Family
ID=43639099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN5209DEN2012 IN2012DN05209A (es) | 2009-11-23 | 2010-11-19 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8629185B2 (es) |
| EP (1) | EP2504313A1 (es) |
| JP (2) | JP5921439B2 (es) |
| KR (1) | KR20120085330A (es) |
| CN (2) | CN102712584B (es) |
| AU (1) | AU2010321831B2 (es) |
| BR (1) | BR112012012387A2 (es) |
| CA (1) | CA2781698A1 (es) |
| CL (1) | CL2012001339A1 (es) |
| CO (1) | CO6551754A2 (es) |
| HK (1) | HK1207570A1 (es) |
| IL (2) | IL219959A (es) |
| IN (1) | IN2012DN05209A (es) |
| MX (1) | MX2012005968A (es) |
| NZ (1) | NZ600263A (es) |
| RU (1) | RU2577546C2 (es) |
| UA (1) | UA110696C2 (es) |
| WO (1) | WO2011063276A1 (es) |
| ZA (1) | ZA201203883B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102712584B (zh) * | 2009-11-23 | 2014-10-29 | 阿勒根公司 | 晶型ii的7-[3,5-二羟基-2-(3-羟基-5-苯基-戊-1-烯基)-环戊基]-n-乙基-庚-5-烯酰胺(比马前列素)、其制备方法和使用方法 |
| US9238621B2 (en) * | 2011-06-02 | 2016-01-19 | Chinoin Zrt | Processes for the preparation of prostaglandin amides |
| EP2911623B1 (en) | 2012-10-26 | 2019-08-14 | Forsight Vision5, Inc. | Ophthalmic system for sustained release of drug to eye |
| ES2846724T3 (es) * | 2012-12-19 | 2021-07-29 | Novartis Ag | Formulaciones de inhibidores de LFA-1 |
| US9447014B2 (en) | 2012-12-28 | 2016-09-20 | Allergan, Inc. | Tromethamine salt of bimatoprost acid in crystalline form, methods for preparation, and methods for use thereof |
| US9120738B2 (en) | 2012-12-28 | 2015-09-01 | Allergan, Inc. | Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof |
| US10273206B2 (en) | 2014-06-27 | 2019-04-30 | Allergan, Inc. | Tromethamine salt of bimatoprost acid in crystalline form 1, methods for preparation, and methods for use thereof |
| US20160296532A1 (en) | 2015-04-13 | 2016-10-13 | Forsight Vision5, Inc. | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent |
| CN115677549A (zh) * | 2022-10-27 | 2023-02-03 | 神隆医药（常熟）有限公司 | 一种贝美前列素手性异构体的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU403156A3 (es) * | 1968-07-29 | 1973-10-19 | ||
| US7166730B2 (en) * | 2000-01-27 | 2007-01-23 | Fine Tech Laboratories, Ltd | Process for the preparation of prostaglandin derivatives |
| IL143477A (en) * | 2001-05-31 | 2009-07-20 | Finetech Pharmaceutical Ltd | Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives |
| WO2002009702A2 (en) * | 2000-07-28 | 2002-02-07 | Inspire Pharmaceuticals, Inc. | Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
| WO2005066256A1 (en) * | 2003-12-30 | 2005-07-21 | Metabolix, Inc. | Nucleating agents |
| IL177762A0 (en) * | 2006-08-29 | 2006-12-31 | Arieh Gutman | Bimatoprost crystalline form i |
| CN102712584B (zh) * | 2009-11-23 | 2014-10-29 | 阿勒根公司 | 晶型ii的7-[3,5-二羟基-2-(3-羟基-5-苯基-戊-1-烯基)-环戊基]-n-乙基-庚-5-烯酰胺(比马前列素)、其制备方法和使用方法 |
-
2010
- 2010-11-19 CN CN201080062129.5A patent/CN102712584B/zh active Active
- 2010-11-19 UA UAA201207505A patent/UA110696C2/uk unknown
- 2010-11-19 WO PCT/US2010/057494 patent/WO2011063276A1/en active Application Filing
- 2010-11-19 AU AU2010321831A patent/AU2010321831B2/en active Active
- 2010-11-19 CN CN201410542159.6A patent/CN104367580A/zh active Pending
- 2010-11-19 NZ NZ600263A patent/NZ600263A/en unknown
- 2010-11-19 IN IN5209DEN2012 patent/IN2012DN05209A/en unknown
- 2010-11-19 KR KR1020127016191A patent/KR20120085330A/ko not_active Application Discontinuation
- 2010-11-19 CA CA2781698A patent/CA2781698A1/en not_active Abandoned
- 2010-11-19 MX MX2012005968A patent/MX2012005968A/es not_active Application Discontinuation
- 2010-11-19 BR BR112012012387A patent/BR112012012387A2/pt not_active IP Right Cessation
- 2010-11-19 JP JP2012541130A patent/JP5921439B2/ja active Active
- 2010-11-19 EP EP10785274A patent/EP2504313A1/en not_active Ceased
- 2010-11-19 RU RU2012125185/04A patent/RU2577546C2/ru active
- 2010-11-22 US US12/951,780 patent/US8629185B2/en active Active
-
2012
- 2012-05-23 CL CL2012001339A patent/CL2012001339A1/es unknown
- 2012-05-23 IL IL219959A patent/IL219959A/en active IP Right Grant
- 2012-05-28 ZA ZA2012/03883A patent/ZA201203883B/en unknown
- 2012-06-22 CO CO12104940A patent/CO6551754A2/es unknown
-
2013
- 2013-12-20 US US14/136,323 patent/US9181176B2/en active Active
-
2015
- 2015-07-12 IL IL239892A patent/IL239892A0/en unknown
- 2015-08-25 HK HK15108218.2A patent/HK1207570A1/xx unknown
-
2016
- 2016-02-05 JP JP2016021287A patent/JP2016094471A/ja not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HK1207570A1 (en) | 2016-02-05 |
| AU2010321831B2 (en) | 2016-07-07 |
| US20110152376A1 (en) | 2011-06-23 |
| RU2577546C2 (ru) | 2016-03-20 |
| JP2013511573A (ja) | 2013-04-04 |
| US8629185B2 (en) | 2014-01-14 |
| CN104367580A (zh) | 2015-02-25 |
| IL239892A0 (en) | 2015-08-31 |
| IL219959A (en) | 2015-07-30 |
| MX2012005968A (es) | 2012-08-15 |
| BR112012012387A2 (pt) | 2019-09-24 |
| CO6551754A2 (es) | 2012-10-31 |
| IL219959A0 (en) | 2012-07-31 |
| UA110696C2 (uk) | 2016-02-10 |
| WO2011063276A1 (en) | 2011-05-26 |
| CN102712584B (zh) | 2014-10-29 |
| AU2010321831A1 (en) | 2012-06-21 |
| JP2016094471A (ja) | 2016-05-26 |
| CN102712584A (zh) | 2012-10-03 |
| ZA201203883B (en) | 2013-01-31 |
| JP5921439B2 (ja) | 2016-05-24 |
| US9181176B2 (en) | 2015-11-10 |
| NZ600263A (en) | 2014-08-29 |
| KR20120085330A (ko) | 2012-07-31 |
| US20140113974A1 (en) | 2014-04-24 |
| RU2012125185A (ru) | 2013-12-27 |
| CA2781698A1 (en) | 2011-05-26 |
| EP2504313A1 (en) | 2012-10-03 |
| CL2012001339A1 (es) | 2012-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN05209A (es) | ||
| JOP20180103A1 (ar) | مركب صيدلاني | |
| IN2012DN02751A (es) | ||
| GEP20156266B (en) | Spiroheterocyclic n-oxypiperidines as pesticides | |
| UA116809C2 (uk) | Застосування агрохімічних сумішей для збільшення життєздатності рослини | |
| MX2013000793A (es) | Composicion que contiene galacto-oligosacarido y un metodo para producirla. | |
| TW200728310A (en) | Process for the preparation of ferri-succinylcasein | |
| MX360872B (es) | Nuevas composiciones para la produccion de poliamidas coladas. | |
| MX2010004546A (es) | Nuevos intermedios de pregabalina y procedimiento para prepararlos y para preparar pregabalina. | |
| MX2009012309A (es) | El uso de hidrofobicos como aditivos en la cristalizacion de solidos. | |
| MY149154A (en) | Novel microbiocides | |
| MX2011011059A (es) | Uso de propineb como repelente de aves. | |
| MX2019009242A (es) | Un proceso novedoso para la sintesis de 1-aril-1-trifluoro-metil-c iclopropanos. | |
| MX2012010443A (es) | Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos. | |
| UA102816C2 (ru) | Способ синтеза кристаллической формы v агомелатина | |
| IN2014DN03245A (es) | ||
| MX342311B (es) | Nuevos compuestos de azaespirodecanona como inhibidores de lipasa sensible a hormonas (hsl). | |
| MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation | |
| IN2012DN02000A (es) | ||
| MX346980B (es) | Nuevos compuestos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona y octahidropiridinona. | |
| EA201400606A1 (ru) | Полиолефиновое волокно | |
| MX2013007504A (es) | Composiciones y metodos de uso de formas cristalinas de analogos de wortmanina. | |
| MX344429B (es) | Nuevos compuestos de hexahidropirroloimidazolona. | |
| WO2014060575A3 (en) | Process for the enantioselective synthesis of a tetrahydrobenzazepine compound | |
| MX351789B (es) | Nueva composicion para la preparación de poliamidas de fundido.. |